BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20054708)

  • 1. Parkinson's disease and cancer risk: a systematic review and meta-analysis.
    Bajaj A; Driver JA; Schernhammer ES
    Cancer Causes Control; 2010 May; 21(5):697-707. PubMed ID: 20054708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease.
    Driver JA; Logroscino G; Buring JE; Gaziano JM; Kurth T
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1260-5. PubMed ID: 17548694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and risk of mortality: meta-analysis and systematic review.
    Xu J; Gong DD; Man CF; Fan Y
    Acta Neurol Scand; 2014 Feb; 129(2):71-9. PubMed ID: 24256347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between Parkinson's disease and melanoma: a systematic review and meta-analysis.
    Huang P; Yang XD; Chen SD; Xiao Q
    Transl Neurodegener; 2015; 4():21. PubMed ID: 26535116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender.
    Lee JYS; Ng JH; Saffari SE; Tan EK
    Aging (Albany NY); 2022 Mar; 14(5):2148-2173. PubMed ID: 35247252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.
    Zhang X; Guarin D; Mohammadzadehhonarvar N; Chen X; Gao X
    BMJ Open; 2021 Jul; 11(7):e046329. PubMed ID: 34215604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Parkinson's disease and risk of prostate cancer in different populations: An updated meta-analysis.
    Chen C; Zheng H; Hu Z
    Sci Rep; 2017 Oct; 7(1):13449. PubMed ID: 29044216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.
    Agalliu I; San Luciano M; Mirelman A; Giladi N; Waro B; Aasly J; Inzelberg R; Hassin-Baer S; Friedman E; Ruiz-Martinez J; Marti-Masso JF; Orr-Urtreger A; Bressman S; Saunders-Pullman R
    JAMA Neurol; 2015 Jan; 72(1):58-65. PubMed ID: 25401981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis.
    Lang Y; Gong D; Fan Y
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):559-66. PubMed ID: 25845582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of lung cancer in Parkinson's disease.
    Xie X; Luo X; Xie M; Liu Y; Wu T
    Oncotarget; 2016 Nov; 7(47):77319-77325. PubMed ID: 27801674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
    Ong EL; Goldacre R; Goldacre M
    Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease.
    Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
    Cancer Causes Control; 2007 Sep; 18(7):705-11. PubMed ID: 17562193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk in Parkinson disease: An updated systematic review and meta-analysis.
    Leong YQ; Lee SWH; Ng KY
    Eur J Neurol; 2021 Dec; 28(12):4219-4237. PubMed ID: 34403556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson's Disease: A Meta-Analysis Assessment.
    Shen L; Ji HF
    Nutrients; 2015 Jun; 7(6):4817-27. PubMed ID: 26083115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2019 Oct; 10(10):4430-4439. PubMed ID: 31584793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macronutrients intake and risk of Parkinson's disease: A meta-analysis.
    Wang A; Lin Y; Wu Y; Zhang D
    Geriatr Gerontol Int; 2015 May; 15(5):606-16. PubMed ID: 25163395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the relationship between Parkinson disease and melanoma.
    Liu R; Gao X; Lu Y; Chen H
    Neurology; 2011 Jun; 76(23):2002-9. PubMed ID: 21646627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between cancer and Parkinson's disease in U.S. elderly adults.
    Freedman DM; Wu J; Chen H; Engels EA; Enewold LR; Freedman ND; Goedert JJ; Kuncl RW; Gail MH; Pfeiffer RM
    Int J Epidemiol; 2016 Jun; 45(3):741-51. PubMed ID: 26989123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.
    Cheng P; Yu J; Huang W; Bai S; Zhu X; Qi Z; Shao W; Xie P
    Neurol Sci; 2015 Dec; 36(12):2269-75. PubMed ID: 26265293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.